2022
DOI: 10.2169/internalmedicine.8366-21
|View full text |Cite
|
Sign up to set email alerts
|

Anti-interferon-γ Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes

Abstract: Disseminated nontuberculous mycobacterial infection (DNTM) is typically observed in immunocompromised hosts. Recently, it has been reported that healthy individuals with serum neutralizing autoantibodies for interferon (IFN)-γ can also develop DNTM. We herein report a case of anti-IFN-γ antibody-seropositive DNTM caused by Mycobacterium kansasii with symptoms mimicking TAFRO or POEMS syndrome, including anasarca, organomegaly, skin pigmentation, polyneuropathy, osteosclerotic change, thr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…These symptoms seemed to be the result of a cytokine storm induced by sepsis but were difficult to distinguish from other causes, such as TAFRO syndrome. There have been several case reports of patients with TAFRO syndrome successfully treated with glucocorticoid treatment or in combination with other immunosuppressants, such as rituximab and tocilizumab [ 14 18 ]. The usefulness of tocilizumab is based on the observation of elevated serum interleukin (IL)-6 levels in patients with TAFRO syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…These symptoms seemed to be the result of a cytokine storm induced by sepsis but were difficult to distinguish from other causes, such as TAFRO syndrome. There have been several case reports of patients with TAFRO syndrome successfully treated with glucocorticoid treatment or in combination with other immunosuppressants, such as rituximab and tocilizumab [ 14 18 ]. The usefulness of tocilizumab is based on the observation of elevated serum interleukin (IL)-6 levels in patients with TAFRO syndrome.…”
Section: Discussionmentioning
confidence: 99%